RECURSION PHARMACEUTICALS, INC. Logo

RECURSION PHARMACEUTICALS, INC.

A clinical-stage company applying AI and machine learning to drug discovery.

RXRX | US

Overview

Corporate Details

ISIN(s):
US75629V1044
LEI:
Country:
United States of America
Address:
41S RIO GRANDE STREET, 84101 SALT LAKE CITY

Description

Recursion Pharmaceuticals is a clinical-stage company that applies artificial intelligence and machine learning to drug discovery. Its central platform, the Recursion Operating System (OS), integrates automated wet-lab biology with advanced computational tools to industrialize the process. By generating vast, proprietary biological and chemical datasets from millions of weekly cellular experiments, the company trains its models to decode biology, identify novel drug targets, and design potential medicines. Recursion's pipeline focuses on developing treatments for conditions with high unmet need, such as rare diseases and aggressive cancers. The company's approach aims to significantly accelerate the drug discovery timeline, improve efficiency, and reduce the high failure rates common in traditional pharmaceutical development.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2024-12-15
English
4.2 MB
2024-10-30
German
1.8 MB
2024-08-14
French
0.5 MB
2024-05-22
English
2.1 MB
2024-03-10
English
3.5 MB
2024-01-15
German
1.2 MB
2023-11-20
English
5.1 MB

Full Filing History Restricted

Access to specific historical documents or filtered results is limited in the Web UI. Request access to the complete dataset.

Automate Your Workflow. Get a real-time feed of all RECURSION PHARMACEUTICALS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for RECURSION PHARMACEUTICALS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for RECURSION PHARMACEUTICALS, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

DG INNOVATE PLC Logo
Develops sustainable technologies for electric mobility and energy storage solutions.
United Kingdom
DGI
Dianthus Therapeutics, Inc. /DE/ Logo
Clinical-stage biotech developing therapies for severe autoimmune diseases.
United States of America
DNTH
Dogwood Therapeutics, Inc. Logo
A biotech company developing novel therapeutics for pain and neuropathy.
United States of America
DWTX
DreamCIS INC. Logo
Contract research organization for pharma, biotech, and medical device industries.
South Korea
223250
DT&CRO CO., Ltd. Logo
A full-service CRO providing non-clinical and clinical studies for various industries.
South Korea
383930
D.Western Therapeutics Institute, Inc. Logo
Biotechnology firm developing drugs from a proprietary protein kinase inhibitor library.
Japan
4576
Ectin Research AB Logo
Pharmaceutical company developing novel oncology treatments, with a lead drug in trials.
Sweden
ECTIN B
EdgeLab S.p.A. Logo
Designs and manufactures marine and underwater solutions, including AUVs and robotics.
Italy
ELB
Editas Medicine, Inc. Logo
A clinical-stage genome editing company developing CRISPR medicines for serious diseases.
United States of America
EDIT
Eledon Pharmaceuticals, Inc. Logo
Clinical-stage biotech developing therapies for organ and autoimmune diseases.
United States of America
ELDN

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.